Avalo Therapeutics
AVTX
AVTX
29 hedge funds and large institutions have $63.2M invested in Avalo Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+8
Holders Change %
+38.1%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
10
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DTC
1
Deep Track Capital
Greenwich,
Connecticut
|
$9.19M |
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$9.19M |
| 3 |
O
3
OrbiMed
New York
|
$9.19M |
| 4 |
BI
4
BVF Inc
San Francisco,
California
|
$9.15M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$9.22M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
26
Parallel Advisors
San Francisco,
California
| $10 | – | – | – |
|
|
JIP
27
Jaffetilchin Investment Partners
Tampa,
Florida
| $10 | +$10 | +1 | New |
|
28
Fidelity Investments
Boston,
Massachusetts
| $9 | -$9 | -1 | -50% |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -590 | Closed |
|
|
BCV
30
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$4K | -338 | Closed |
|